In Brief
Refine Search
Pharmaceutical
As part of its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the USA’s Federal Trade Commission (FTC) has issued a compulsory order to a third group purchasing organization (GPO) that negotiates drug rebates on behalf of PBMs. 9 June 2023
Biotechnology
The UK and Ireland division of LEO Pharma has appointed Leanne Walsh as general manager. 8 June 2023
Pharmaceutical
The US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Injectafer (ferric carboxymaltose injection), Japanese drugmaker Daiichi Sankyo and its US subsidiary, American Regent, have announced. 7 June 2023
Biotechnology
Swiss biotech Idorsia revealed that it has entered into exclusive negotiations with an undisclosed party regarding its operating businesses in the Asia Pacific (ex-China) region, including selected license rights to products from Idorsia’s portfolio in those territories, for a total consideration of up to 400 million francs ($411 million). 6 June 2023
Biotechnology
US biotech major Biogen announced plans to revise the clinical development program for BIIB122, a small molecule inhibitor of leucine-rich repeat kinase 2 (LRRK2), which is being developed in collaboration with Denali Therapeutics. 5 June 2023
Biotechnology
The Food and Drug Administration (FDA) announced it had revoked the emergency use authorization (EUA) of the COVID-19 Vaccine Janssen. 3 June 2023
Biotechnology
The management board of BioNTech, with the approval of the supervisory board, resolved to carry out a share buyback program of American Depositary Shares (ADSs) of BioNTech (ISIN: US09075V1026) with a value of up to $5 million. 2 June 2023
Pharmaceutical
The US Federal Trade Commission and the US Department of Justice, Antitrust Division released a summary of a two-day workshop that explored new approaches to enforcement of the antitrust laws in the pharmaceutical industry. 2 June 2023
Biotechnology
London, UK-based invoX Pharma, a subsidiary of China’s Sino Biopharmaceutical, has increased its stake in mRNA vaccine company pHion Therapeutics, by an undisclosed amount. 1 June 2023
Biotechnology
Citing an unfavorable competitive landscape for the product, AstraZeneca today announced the discontinuation of the brazikumab inflammatory bowel disease (IBD) development program, an anti-interleukin (IL)-23 monoclonal antibody, being investigated for the treatment of Crohn’s disease (CD) and ulcerative colitis (UC). 1 June 2023
Biotechnology
Privately-held Swedish company Anocca has raised around $36 million through an equity financing round led by AMF and Mellby Gård. 31 May 2023
Biotechnology
China-headquartered biotech BeiGene today revealed that its Brukinsa (zanubrutinib), a Bruton's tyrosine kinase inhibitor (BTKi) has been approved by Health Canada for the treatment of adult patients with chronic lymphocytic leukemia (CLL). 31 May 2023
Pharmaceutical
The British business of Pfizer has announced a positive reimbursement decision for Vydura (rimegepant), unlocking the migraine med’s routine use in England and Wales. 31 May 2023
Pharmaceutical
Atea Pharmaceuticals today announced that its board of directors unanimously rejected the unsolicited proposal from Tang Capital Partners, on behalf of Concentra Biosciences, to acquire all outstanding common shares of Atea for $5.75 per share in cash, plus a contingent value right representing the right to receive 80% of the net proceeds payable from any license or disposition of Atea’s programs. 30 May 2023
Biotechnology
US healthcare giant Johnson & Johnson subsidiary Janssen has submitted a Type II variation application to the European Medicines Agency (EMA) seeking approval of a new indication for Carvykti (ciltacabtagene autoleucel; cilta-cel) for the treatment of adult patients with relapsed and lenalidomide-refractory multiple myeloma. 30 May 2023
Biotechnology
Antibody-drug conjugate (ADC) specialists Adcendo and Duality Biologics have expanded an existing collaboration to develop ADCs, just a few months after they started working together. 30 May 2023
Biotechnology
US pharma giant Pfizer and German partner BioNTech today announced they have reached an agreement with the European Commission (EC) to amend their existing contract to deliver COVID-19 vaccines to the European Union. 26 May 2023
Pharmaceutical
Japanese drug major Astellas Pharma said today that its Dutch subsidiaries have made an intended decision to sell and transfer its manufacturing plant, located in Meppel, Netherlands, to Delpharm Industrie SAS. 25 May 2023
Biotechnology
Brighton, UK-based infectious disease specialist Destiny Pharma has announced the resignation of chief executive Neil Clark, with immediate effect. 25 May 2023
Biotechnology
According to the latest report from IQVIA Institute for Human Data Science, global oncology R&D activity remains high and more patients have been treated for cancer. 25 May 2023
Biotechnology
Japanese drugmaker Takeda has launched Fruzaqla (fruquintinib) in its home country. 22 November 2024
Biotechnology
Chinese biopharma CStone Pharmaceuticals has announced a strategic commercial collaboration with Pharmalink Store, a prominent pharmaceutical company based in the United Arab Emirates (UAE). 22 November 2024
Biotechnology
Zhongshan-based biopharma company Akeso will await the verdict of the Chinese medicines regulator on a penpulimab-based combo therapy. 22 November 2024
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Pharmaceutical
Shanghai-based Zai Lab and New York’s Pfizer are to work together on the commercialization of Xacduro (sulbactam-durlobactam) in China. 22 November 2024
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
British pharma major AstraZeneca is facing challenges in its bid to secure full approval for its anticoagulant reversal therapy, Andexxa (andexanet alfa), in the USA. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
Privately-held US biotech Alloy Therapeutics has announced a strategic collaboration and license agreement with Takeda Pharmaceutical. 21 November 2024
Pharmaceutical
Japanese drugmaker Eisai has announced that the amyotrophic lateral sclerosis (ALS) treatment Rozebalamin for Injection (mecobalamin) has been launched in Japan as a treatment for slowing progression of functional impairment in amyotrophic lateral sclerosis. 21 November 2024
Pharmaceutical
Germany's Merck has spent more than 25 years researching and developing solutions for advancing multiple sclerosis (MS) care. 21 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Pharmaceutical
Swiss pharma giant Novartis today announced an upgrade to its mid-term guidance, in advance of its Meet Novartis Management event for investors and analysts in London. 21 November 2024
Biotechnology
The US Food and Drug Administration (FDA) has granted accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for injection for intravenous use, say the drug’s developer, Jazz Pharmaceuticals. 21 November 2024
Biotechnology
Eli Lilly is not resting on its laurels when it comes to the fast-growing field of obesity treatments, an area in which it is already a leader. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
Biotechnology
Astellas Pharma has been hit by bad news from the US Food and Drug Administration, which will not currently approve the firm’s request to supplement the label for Izervay (avacincaptad pegol). 21 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze